31
Mar
New Delhi: Efforts to find a treatment for mitochondrial disorders is set to get a major boost with a team of researchers at the Department of Biotechnology’s National Institute of Immunology (DBT-NII) figuring out a way to tackle autosomal dominant progressive external ophthalmoplegia (adPEO), which is a widely prevalent mitochondrial disorder. Mitochondrial genetic disorders refer to a group of conditions that affect the mitochondria, the structures in the body cells that are responsible for making energy. People with these conditions can be of any age with almost any affected body system. However, the brain, muscles, heart, liver, nerves, eyes, ears…